Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Stifel Maintains Buy on MaxLinear, Raises Price Target to $30

Author: Benzinga Newsdesk | July 18, 2024 11:43am
Stifel analyst Tore Svanberg maintains MaxLinear (NASDAQ:MXL) with a Buy and raises the price target from $26 to $30.

Posted In: MXL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist